Abstract: Provided are novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, compositions containing them and their use in the treatment of or prevention of diseases associated with or characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).

Abstract: Compounds of Formula (I) or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising these compounds, the use of these compounds and compositions in the treatment of diseases in which LRRK-2 kinase is involved.

Abstract: The present disclosure relates to the field of quantum dot display technology and discloses a method for manufacturing a quantum dot display device. The method comprises: providing an array substrate and a counter substrate opposite to each other; printing an alignment solution containing a quantum dot material onto a side of the array substrate facing the counter substrate; removing a solvent in the alignment solution printed onto the side of the array substrate facing the counter substrate; heating the array substrate after removal of the solvent; and providing a backlight source at a side of the array substrate facing away from the counter substrate. The present disclosure further relates to a corresponding quantum dot display device. With such a manufacturing method, the display quality of the resulting quantum dot display device is greatly improved, and the associated manufacturing cost and process difficulty are reduced.

Abstract: The present disclosure relates to the field of quantum dot display technology and discloses a method for manufacturing a quantum dot display device. The method comprises: providing an array substrate and a counter substrate opposite to each other; printing an alignment solution containing a quantum dot material onto a side of the array substrate facing the counter substrate; removing a solvent in the alignment solution printed onto the side of the array substrate facing the counter substrate; heating the array substrate after removal of the solvent; and providing a backlight source at a side of the array substrate facing away from the counter substrate. The present disclosure further relates to a corresponding quantum dot display device. With such a manufacturing method, the display quality of the resulting quantum dot display device is greatly improved, and the associated manufacturing cost and process difficulty are reduced.